Key statistics
As of last trade Natera Inc (NTRA:NSQ) traded at 205.26, -19.93% below its 52-week high of 256.36, set on Jan 07, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 195.67 |
|---|---|
| High | 205.81 |
| Low | 192.60 |
| Bid | 204.69 |
| Offer | 205.83 |
| Previous close | 200.17 |
| Average volume | 1.21m |
|---|---|
| Shares outstanding | 141.73m |
| Free float | 133.61m |
| P/E (TTM) | -- |
| Market cap | 28.37bn USD |
| EPS (TTM) | -1.53 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 17:29 GMT.
More ▼
- Signatera™ MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation
- Natera Reports Fourth Quarter and Full Year 2025 Financial Results
- Successful Readout of Prospective Phase 2 SINERGY Trial Supports SignateraTM MRD-Guided Treatment in Head and Neck Cancer
- Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026
- Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
- Natera Submits Signatera™ CDx PMA to FDA
- Natera Announces Completion of Enrollment in Randomized ACES-EMB Trial in Heart Transplantation
- Prospera™ Featured in Landmark Interventional Study Advancing Lung Transplant Care
- Natera Publishes Clinical Validation of Latitude™ Tissue-Free MRD Test in Colorectal Cancer
- Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting
More ▼
